Solventum (SOLV) | Stock Overview & Key Data
Solventum Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $96.05 on March 25, 2024
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Solventum
SOLV
|
11.96B Large-cap | 0.21% | 13.33% | 4.70% | -10.70% | -3.28% | 2.54% | 7.76% | 7.76% | 7.76% | 7.76% | 7.76% |
|
Intuitive Surgical
ISRG
|
170.06B Large-cap | -7.91% | -11.11% | -18.97% | -29.17% | -28.45% | -23.12% | 36.02% | 53.22% | 500.11% | 1,016.59% | 3,163.95% |
| 56.10B Large-cap | -2.25% | -1.28% | -18.19% | -3.55% | -5.76% | 8.43% | -25.68% | -20.29% | 13.34% | 123.65% | 215.10% | |
|
Alcon
ALC
|
45.84B Large-cap | -5.05% | -12.52% | -24.09% | -18.84% | -17.16% | -22.86% | -16.57% | -5.58% | 21.79% | 21.79% | 21.79% |
|
ResMed
RMD
|
32.03B Large-cap | -12.09% | -12.70% | -28.97% | -27.12% | -25.32% | -22.15% | -13.63% | -7.18% | 220.07% | 499.84% | 738.04% |
| 22.07B Large-cap | -1.27% | 3.99% | 24.25% | 14.34% | 12.94% | 53.10% | -6.09% | -3.19% | 328.98% | 1,367.32% | 1,736.23% |
Ownership & Short Interest
Calculate Your Solventum Investment Returns
Long-Term Investment Performance Analysis
Solventum stock price in Mar 2024 was $69.55, A $1,000.00 lump sum investment in Solventum made 2 years ago would be worth approximately $1,126.67 today, representing a positive return of 12.67%. This translates to an annualized return (CAGR) of 5.60%.
2 Years 2 Months Investment Scenario (Mar 2024 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is SOLV's 52-week high and low?
- In the last 52 weeks, Solventum reached a high of $88.20 (on December 2, 2025) and a low of $62.38 (on April 7, 2026).
- What is the market cap and P/E ratio for SOLV?
- Curious about Solventum's size and valuation? Its market capitalization stands at 11.96B. When it comes to valuation, the P/E ratio (trailing twelve months) is 7.78, and the forward P/E (looking ahead) is 9.83.
- Does SOLV pay dividends? If so, what's the yield?
- As for dividends, Solventum isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Solventum's main competitors or similar companies to consider before investing?
When looking at Solventum, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Intuitive Surgical
ISRG170.06B Healthcare Medical Instruments & Supplies -23.12% 36.02% Becton, Dickinson
BDX56.10B Healthcare Medical Instruments & Supplies 8.43% -25.68% Alcon
ALC45.84B Healthcare Medical Instruments & Supplies -22.86% -16.57% ResMed
RMD32.03B Healthcare Medical Instruments & Supplies -22.15% -13.63% West Pharmaceutical
WST22.07B Healthcare Medical Instruments & Supplies 53.10% -6.09% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Solventum Corp? (e.g., ROE, Debt/Equity)
- To get a sense of Solventum's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 38.86%, the Debt to Equity ratio from the most recent quarter is 103.94, and its Gross Profit Margin stands at 51.40%.
- What is the recent revenue and earnings growth for SOLV?
- Looking at Solventum's growth, its revenue over the trailing twelve months (TTM) was $8B. Compared to the same quarter last year (YoY), quarterly revenue grew by -3.70%, and quarterly earnings saw a YoY growth of 103.20%.
- How much of SOLV stock is held by insiders and institutions?
- Wondering who owns Solventum stock? Company insiders (like executives and directors) hold about 14.99% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 73.68%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.